Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Shares Outstanding (Weighted Average) (2020 - 2026)

Journey Medical filings provide 6 years of Shares Outstanding (Weighted Average) readings, the most recent being $24.5 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 19.9% to $24.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $24.5 million, a 19.9% increase, with the full-year FY2025 number at $24.5 million, up 19.9% from a year prior.
  • Shares Outstanding (Weighted Average) hit $24.5 million in Q4 2025 for Journey Medical, down from $25.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $25.0 million in Q3 2025 to a low of $9.2 million in Q1 2021.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $18.1 million (2023), compared with a mean of $17.8 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): increased 0.3% in 2021 and later skyrocketed 92.33% in 2022.
  • Journey Medical's Shares Outstanding (Weighted Average) stood at $10.2 million in 2021, then surged by 72.05% to $17.5 million in 2022, then grew by 4.0% to $18.2 million in 2023, then rose by 12.06% to $20.4 million in 2024, then rose by 19.9% to $24.5 million in 2025.
  • The last three reported values for Shares Outstanding (Weighted Average) were $24.5 million (Q4 2025), $25.0 million (Q3 2025), and $23.3 million (Q2 2025) per Business Quant data.